gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

Radiosurgery for intracranial hemangiopericytomas

Meeting Abstract

Search Medline for

  • Antonio Santacroce - Universitätsklinikum Tübingen, Klinik für Neurochirurgie, Tübingen, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie. Münster, 03.-06.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocV093

doi: 10.3205/18dgnc094, urn:nbn:de:0183-18dgnc0941

Published: June 18, 2018

© 2018 Santacroce.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Intracranial hemangiopericytoma is a rare CNS tumor that exhibits a high incidence of localrecurrence and distant metastasis. The purpose of this study was to evaluate the role of Gamma Knife Radiosurgery (GKRS) in themanagement of intracranial hemangiopericytomas.

Methods: From 15 participating centers under the auspices of the european gamma knife Society weperformed a retrospective observational analysis of a cohort of 115 hemangiopericytomas treatedwith GKRS. All were treated with Gamma Knife radiosurgery at least 5 years before assessment for this study. Clinical and imaging data were retrieved from each center and uniformly entered into a database by1 author (A.S.). A statistical analysis is presented.

Results: 77 patients harbouring 115 hemangiopericytomas treated in fifteen institutions recruited wereevaluated. The median age was 47 years (range 16-77 years). The median tumour volume was 3.30 ccm (range 0.1-20,4 ccm) and tumour margin dose to the 50% isodose line 15.0 Gy (range 10-40 Gy). The median radiological Follow Up was 47 months, but detailed results were only available for 92hemangiopericytomas (80%). The volume of treated tumours decreased in 22 lesions (24%) did notchange in 29 lesions (32%) and increased in 41 lesions (45%). The temporary morbidity rate after GKRS was 2.1% and the permanent morbidity rate was 2.6%. The actuarial control rate was 66% at 5 years post GKRS. A main limitation is the retrospective nature of data retrieval.

Conclusion: GKRS is a safe and not invasive method of treatment of hemangiopericytomas. The large number analyzed confirms a high tumour control and low morbidity rate even after a longterm follow up period.